Have you ever wondered “how long does the yellow fever vaccine last?” For most healthy adults, a single dose of the yellow fever vaccine provides lifelong protection; a position adopted by the World Health Organization in 2016 and subsequently incorporated into UK guidance by NaTHNaC and UKHSA. This means that the vast majority of travellers who have received the vaccine at any point in their life do not need a booster dose before returning to yellow fever endemic areas, and their International Certificate of Vaccination or Prophylaxis (ICVP) is now accepted as valid indefinitely under the International Health Regulations. There are, however, specific groups for whom a booster may still be recommended, including those who were vaccinated before the age of two, those who were pregnant at the time of vaccination, and individuals who were immunocompromised when they received their original dose. At Edinburgh Travel Clinic, our specialist travel health nurses review your vaccination history and individual circumstances to confirm whether your yellow fever protection is current and whether any additional doses are required before your next trip.
Our specialist travel health team at Edinburgh Travel Clinic will review your vaccination history, assess your current immune status, and advise on whether a booster is needed before your next trip. Book a consultation today and travel knowing your status is fully confirmed.
Key Takeaways
- Since 2016, a single dose of the yellow fever vaccine is considered to provide lifelong protection for most healthy adults.
- Under the International Health Regulations, a valid ICVP cannot be rejected because more than 10 years have passed since vaccination.
- Certain groups may still require a booster, including those vaccinated before age two, during pregnancy, or while immunocompromised.
- In Scotland, yellow fever vaccination centres are designated through Public Health Scotland; Edinburgh Travel Clinic is a fully accredited designated centre.
- The vaccine must be given at least 10 days before travel for the ICVP to become legally valid.
- Some countries require proof of yellow fever vaccination as a mandatory entry requirement, regardless of travel history.
The 2016 WHO Guidance Change
Prior to 2016, the yellow fever vaccine was considered to provide protection for ten years, after which a booster was required to renew both immunity and the validity of the ICVP. In 2016, the World Health Organization updated its position based on extensive immunological evidence demonstrating that immunity following a single dose of the yellow fever vaccine is durable and, for the vast majority of healthy recipients, lifelong.
This change was significant for several reasons. From a practical standpoint, it meant that millions of travellers who had previously been told their yellow fever vaccination had expired were, in fact, still protected. From a regulatory standpoint, it meant that under the International Health Regulations, a valid ICVP cannot be rejected on the grounds that more than ten years have passed since vaccination. The ICVP issued following a single vaccination is therefore now accepted as valid indefinitely by all countries that are signatories to the International Health Regulations.
In the UK, NaTHNaC and UKHSA adopted the WHO position, and UK-issued ICVPs no longer carry a ten-year expiry for most recipients. Always check the most current entry requirements for your specific destination with your travel health clinician or via the NaTHNaC TravelHealthPro website before you travel, as some individual country requirements may differ from International Health Regulations obligations.
Who Still Needs a Yellow Fever Booster?
While the single-dose lifelong protection policy applies to the majority of healthy adults, there are specific groups for whom a booster dose may still be clinically recommended. An assessment of whether you belong to one of these groups is a critical step in determining whether your existing yellow fever vaccination is sufficient for your next trip or whether a booster is needed.
Groups Who May Still Need a Booster
- Those vaccinated before the age of two years, as immune responses in very young children may be less durable.
- Women who were pregnant at the time of their original vaccination, as pregnancy can affect the immune response to live vaccines.
- Individuals who were immunocompromised when they received their original dose, including those on immunosuppressive therapy at the time.
- Those who received a haematopoietic stem cell transplant after their original vaccination, as this process can reset immune memory.
- People living with HIV who were vaccinated when their CD4 count was low, as their immune response to the vaccine may have been inadequate.
If any of these circumstances apply to you, Edinburgh Travel Clinic’s specialist team can review your vaccination history, assess your current immune status, and advise on whether a booster is appropriate before your next trip to a yellow fever risk area. In some cases, antibody titre testing may be used to assess the level of existing immunity before a decision is made.
Yellow Fever Vaccine Duration
The following table summarises whether a booster dose is recommended based on the circumstances of original vaccination, to help you understand where you stand before your pre-travel consultation.
| Circumstance of Original Vaccination | Booster Recommended? | Notes |
|---|---|---|
| Healthy adult, vaccinated aged 2 or over | No | Single dose considered lifelong — ICVP valid indefinitely under the International Health Regulations |
| Vaccinated before age 2 | Yes | Immune response in very young children may be less durable |
| Vaccinated during pregnancy | Yes | Pregnancy can reduce immune response to live vaccines |
| Vaccinated while immunocompromised | Yes | Reduced immune response at time of vaccination may mean protection was inadequate |
| Vaccinated prior to a stem cell transplant | Yes | Transplant resets immune memory — re-vaccination required when clinically appropriate |
| Living with HIV, vaccinated with low CD4 count | Seek advice | Antibody titre testing may be recommended — individual clinical assessment required |
| Aged 60 or over, receiving first dose | Seek advice | Individual risk-benefit assessment recommended before first vaccination — previously vaccinated healthy adults in this age group do not routinely require a booster |
The International Certificate of Vaccination or Prophylaxis (ICVP)
The ICVP, commonly known as the yellow card or yellow booklet, is the official document that proves you have received the yellow fever vaccine. It is a legally recognised document under the International Health Regulations and is required for entry to a number of countries in sub-Saharan Africa and South America, either for all incoming travellers or for those arriving from yellow fever endemic countries.
Facts About Your ICVP
Your ICVP becomes valid 10 days after vaccination and is accepted as valid indefinitely for most travellers following a single dose. Under the International Health Regulations, a valid ICVP cannot be rejected on the grounds that more than 10 years have passed since vaccination. It must be signed and stamped by a registered vaccinator at a designated yellow fever centre to be legally recognised; certificates issued outside of designated centres are not valid. Always carry your original ICVP when travelling to countries that require it, as photocopies are not accepted. If you have lost your ICVP, Edinburgh Travel Clinic can advise on the options available for obtaining a replacement or re-vaccination where appropriate.
Always check the most current entry requirements for your specific destination with your travel health clinician or via the NaTHNaC TravelHealthPro website before you travel, as individual country requirements may vary and are subject to change.
The Importance of Designated Yellow Fever Centres
Unlike most other travel vaccines, the yellow fever vaccine is tightly regulated in the UK and can only be administered at officially designated yellow fever vaccination centres. In England, Wales, and Northern Ireland, centres are designated through NaTHNaC on behalf of the UK government. In Scotland, yellow fever vaccination centres are designated through Public Health Scotland. Edinburgh Travel Clinic is a fully accredited designated yellow fever vaccination centre under this framework.
This designation requirement exists for several important reasons. The vaccine is a live attenuated vaccine that requires careful storage and handling to maintain potency. It carries specific and important contraindications that must be assessed by a qualified clinician before administration. And the resulting ICVP must be officially signed and stamped by a registered vaccinator at a designated centre to be internationally recognised and legally valid.
Our specialist team carries out a thorough pre-vaccination assessment before every dose to confirm suitability, discuss the risk of rare but serious adverse events including yellow fever vaccine-associated viscerotropic disease (YEL-AVD) and yellow fever vaccine-associated neurotropic disease (YEL-AND), and ensure every patient leaves their appointment fully informed and with the best available protection in place before their trip.
Getting your yellow fever vaccine from a fully accredited designated centre means every aspect of your vaccination meets the highest regulatory standards. Call us to book your consultation today.
Who Should Not Have the Yellow Fever Vaccine?
The yellow fever vaccine is highly effective and well-tolerated by the majority of healthy adults, but it is not suitable for everyone. Because it is a live attenuated vaccine, it is contraindicated in certain groups where the live virus component could pose a risk.
The vaccine is contraindicated in infants under six months of age. If your infant is aged between six and eight months, the yellow fever vaccine may be considered in exceptional circumstances where exposure risk is judged to be high by a specialist clinician who has carried out a thorough individual risk assessment. The vaccine is generally recommended from nine months of age as standard practice, though it should be used with caution in infants aged nine to 23 months due to a small increased risk of vaccine-associated encephalitis in this age group.
Regarding egg allergy, it is important to note that mild egg allergy is not a contraindication; those with mild egg allergy should discuss their individual circumstances with their clinician, as they may still be able to receive the vaccine under appropriate supervision. A history of anaphylaxis to egg, however, is a contraindication to yellow fever vaccination and must be disclosed at the pre-vaccination assessment. Those with a thymus disorder or who are severely immunocompromised should not receive the vaccine due to the risk of uncontrolled replication of the vaccine virus.
The vaccine should also be used with caution in adults aged 60 and over, and particularly those aged 65 and over who are receiving their first dose, as the risk of rare but serious adverse events is higher in this group. A careful individual risk-benefit assessment is always recommended for older travellers receiving the vaccine for the first time. Previously vaccinated healthy adults in this age group do not routinely require a booster on the basis of age alone. During pregnancy, the vaccine is generally avoided unless the risk of yellow fever exposure is considered unavoidable, in which case the decision should be made on an individual basis with a healthcare professional.
Travellers who are medically contraindicated for the yellow fever vaccine may be issued a letter of medical exemption, which must be signed by a registered clinician at a designated yellow fever vaccination centre to be considered valid. It is important to be aware, however, that not all countries accept exemption letters in lieu of a valid ICVP, and that travelling to a yellow fever endemic area without vaccination carries a genuine and serious health risk.
Yellow Fever Risk Destinations
Yellow fever is endemic across tropical regions of sub-Saharan Africa and South America, and the level of risk varies significantly between and within countries. A thorough assessment of the specific yellow fever risk profile of your destination is a fundamental component of comprehensive pre-travel health planning and should always form part of your consultation with a travel health specialist.
In sub-Saharan Africa, countries with the highest yellow fever burden include Nigeria, Ghana, Cameroon, the Democratic Republic of Congo, Uganda, Ethiopia, and Angola. The risk is predominantly associated with rural and forested areas, though urban transmission has been documented during periods of heightened outbreak activity. In South America, Brazil carries the highest risk, particularly in the Amazon and Pantanal regions, alongside Bolivia, Peru, Colombia, Ecuador, and Venezuela. Risk levels within countries can vary enormously between coastal urban areas and interior jungle regions.
Some countries that are not themselves yellow fever endemic require proof of vaccination from travellers arriving from endemic countries, to prevent importation of the disease. This means that even travellers transiting through an endemic country at an airport may be required to present a valid ICVP on arrival at their final destination. Your travel health clinician can advise on the specific vaccination requirements for your full itinerary, including any transit stops.
Every destination carries its own unique yellow fever risk profile and our specialist team at Edinburgh Travel Clinic will give you a clear picture of what that means for your specific trip. Contact us to book your consultation today.
Frequently Asked Questions
We have answered the yellow fever vaccine questions our travellers ask us most often below and our specialist team is always on hand if you need more personalised advice.
The Importance of the Yellow Fever Vaccine
Whether you received the yellow fever vaccine years ago and are wondering whether it is still valid, or whether you are preparing for your first trip to an endemic region and need the vaccine for the first time, understanding the current guidance is essential before you travel. The shift to lifelong protection following a single dose has been one of the most significant changes in travel health in recent years; but the nuances around who may still need a booster, the specific rules around infant vaccination, and who cannot receive the vaccine mean that professional guidance remains as important as ever.
At Edinburgh Travel Clinic, our specialist travel health team will confirm whether your existing certificate remains valid, administer a first dose and issue your ICVP if needed, or assess whether a booster is appropriate based on your health history. Do not leave your yellow fever status to guesswork. Book now and travel with the confidence that comes from expert, personalised travel health care.